These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1898378)

  • 41. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An effective chromatographic separation of chicken red blood cell coproporphyrinogen oxidase and uroporphyrinogen decarboxylase, two enzymes in heme biosynthesis.
    Jones MA; Taneja M; Xu Y; Chung W; Stob CM; Lash TD
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5559-64. PubMed ID: 15482924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on porphyrin metabolism in the kidney. Effects of trace metals and glutathione on renal uroporphyrinogen decarboxylase.
    Woods JS; Eaton DL; Lukens CB
    Mol Pharmacol; 1984 Sep; 26(2):336-41. PubMed ID: 6482878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified uroporphyrinogen decarboxylase activity in a yeast mutant which mimics porphyria cutanea tarda.
    Rytka J; Bilinski T; Labbe-Bois R
    Biochem J; 1984 Mar; 218(2):405-13. PubMed ID: 6370240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicity of polychlorinated biphenyl with special reference to porphyrin metabolism.
    Sano S; Kawanishi S; Seki Y
    Environ Health Perspect; 1985 Feb; 59():137-43. PubMed ID: 3921356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human uroporphyrinogen III synthase: NMR-based mapping of the active site.
    Cunha L; Kuti M; Bishop DF; Mezei M; Zeng L; Zhou MM; Desnick RJ
    Proteins; 2008 May; 71(2):855-73. PubMed ID: 18004775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Organ porphyrins and uroporphyrinogen decarboxylase activity in a case of non-functioning adrenocortical carcinoma.
    Zawirska B
    Mater Med Pol; 1990; 22(2):79-81. PubMed ID: 2102982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evidence for a spirocyclic intermediate in the formation of uroporphyrinogen III by cosynthase.
    Leeper FJ
    Ciba Found Symp; 1994; 180():111-23; discussion 124-30. PubMed ID: 7842849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver.
    Elder GH; Tovey JA; Sheppard DM
    Biochem J; 1983 Oct; 215(1):45-55. PubMed ID: 6626181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of the molecular chaperone HtpG with uroporphyrinogen decarboxylase in the cyanobacterium Synechococcus elongatus PCC 7942.
    Saito M; Watanabe S; Yoshikawa H; Nakamoto H
    Biosci Biotechnol Biochem; 2008 May; 72(5):1394-7. PubMed ID: 18460784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of the thioctamide in relation to the hexachlorobenzene action].
    Vilas GL; Ureta D; Sanchez García MC; Aldonatti C; San Martín de Viale LC; Ríos de Molina MC
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):137-45. PubMed ID: 9777036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer.
    Ito E; Yip KW; Liu FF
    Future Oncol; 2011 May; 7(5):595-7. PubMed ID: 21568673
    [No Abstract]   [Full Text] [Related]  

  • 56. The alternative pathway of haem synthesis via dehydroisocoproporphyrinogen in mutants of Saccharomyces cerevisiae partially deficient in uroporphyrinogen decarboxylase activity.
    Kurlandzka A; Zoladek T; Rytka J; Labbe-Bois R
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):246-7. PubMed ID: 1989588
    [No Abstract]   [Full Text] [Related]  

  • 57. Purification and properties of uroporphyrinogen III synthase (co-synthetase) from Euglena gracilis.
    Hart GJ; Battersby AR
    Biochem J; 1985 Nov; 232(1):151-60. PubMed ID: 3936481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of uroporphyrinogen decarboxylase to the hematopoietic demands of the spleen.
    Woods JS; Kardish RM
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):389-400. PubMed ID: 4023421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid.
    Urquhart AJ; Elder GH; Roberts AG; Lambrecht RW; Sinclair PR; Bement WJ; Gorman N; Sinclair JA
    Biochem J; 1988 Jul; 253(2):357-62. PubMed ID: 3178718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variation of iron-induced uroporphyria in mice.
    Smith AG; Francis JE
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):29-35. PubMed ID: 8471047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.